The Angio-Seal™ femoral closure device allows immediate ambulation after coronary angiography and percutaneous coronary intervention

EuroIntervention

Volumn 7, Issue 2, 2011, Pages 234-241

  Hvelplund, Anders ^a,b   Jeger, Raban ^c   Osterwalder, Remo ^c   Bredahl, Majken ^a   Madsen, Jan Kyst ^a   Jensen, Jan Skov ^a   Kaiser, Christoph ^c   Pfisterer, Matthias ^c   Galatius, Soren ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Angiography; Angioplasty; Vascular closure

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FONDAPARINUX; GLYCOPROTEIN P INHIBITOR;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR EQUIPMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEVICE SAFETY; FALSE ANEURYSM; FEMALE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; SYNCOPE; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMORAL ARTERY; HEMOSTASIS; INSTRUMENTATION; MIDDLE AGED; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; EARLY AMBULATION; FEMALE; FEMORAL ARTERY; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED;

EID: 80054052996     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I2A38     Document Type: Article

References (34)

1. Applegate RJ, Sacrinty M, Kutcher MA, Gandhi SK, Baki TT, Santos RM, Little WC. Vascular complications with newer generations of angioseal vascular closure devices. J Interv Cardiol 2006;19:67-74.
2. Arora N, Matheny ME, Sepke C, Resnic FS. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J 2007;153:606-11. (Pubitemid 46440677)
3. Cura FA, Kapadia SR, L'Allier PL, Schneider JP, Kreindel MS, Silver MJ, Yadav JS, Simpfendorfer CC, Raymond RR, Tuzcu EM, Franco I, Whitlow PL, Topol EJ, Ellis SG. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol 2000;86:780-2, A9.
4. Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993;22:1273-9. (Pubitemid 23316345)
5. Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA, Cutlip DE, Fitzpatrick M, Ho KK, Kuntz RE. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. Am J Cardiol 2000;85:864-9. (Pubitemid 30157854)
6. Magosaki N, Hosoda S, Kawagishi N, Yamaguchi T, Sakatani H, Haze K, Itagane H, Otsuka M, Nobuyoshi M, Yokoi H. [Efficacy of hemostatic puncture closing device for hemostasis and early ambulation after coronary angiography and angioplasty: results of a multicenter trial]. J Cardiol 1999;34:131-8.
7. Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993;22:1273-9. (Pubitemid 23316345)
8. Behan MW, Large JK, Patel NR, Lloyd GW, Sulke AN. A randomised controlled trial comparing the routine use of an Angio-Seal STS device strategy with conventional femoral haemostasis methods in a district general hospital. Int J Clin Pract 2007;61:367-72.
9. Fram DB, Giri S, Jamil G, Mitchel JF, Boden WE, Din S, Kiernan FJ. Suture closure of the femoral arteriotomy following invasive cardiac procedures: a detailed analysis of efficacy, complications, and the impact of early ambulation in 1,200 consecutive, unselected cases. Catheter Cardiovasc Interv 2001;53:163-73. (Pubitemid 32532175)
10. Rinder MR, Tamirisa PK, Taniuchi M, Kurz HI, Mumm K, Lasala JM. Safety and efficacy of suture-mediated closure after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001;54:146-51. (Pubitemid 32953271)
11. Pfisterer M, Bertel O, Bonetti PO, Brunner-La Rocca HP, Eberli FR, Erne P, Galatius S, Hornig B, Kiowski W, Pachinger O, Pedrazzini G, Rickli H, De SS, Kaiser C. Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design. Am Heart J 2008;155:609-14.
12. Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993;22:1273-9. (Pubitemid 23316345)
13. Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA, Cutlip DE, Fitzpatrick M, Ho KK, Kuntz RE. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. Am J Cardiol 2000;85:864-9. (Pubitemid 30157854)
14. Ansel G, Yakubov S, Neilsen C, Allie D, Stoler R, Hall P, Fail P, Sanborn T, Caputo RP. Safety and efficacy of staple-mediated femoral arteriotomy closure: results from a randomized multicenter study. Catheter Cardiovasc Interv 2006;67:546-53.
15. Hermiller JB, Simonton C, Hinohara T, Lee D, Cannon L, Mooney M, O'Shaughnessy C, Carlson H, Fortuna R, Zapien M, Fletcher DR, DiDonato K, Chou TM. The StarClose Vascular Closure System: interventional results from the CLIP study. Catheter Cardiovasc Interv 2006;68:677-83. (Pubitemid 44721086)
16. Resnic FS, Blake GJ, Ohno-Machado L, Selwyn AP, Popma JJ, Rogers C. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol 2001;88:493-6. (Pubitemid 32778493)
17. Tavris DR, Gallauresi BA, Lin B, Rich SE, Shaw RE, Weintraub WS, Brindis RG, Hewitt K. Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. J Invasive Cardiol 2004;16:459-64. (Pubitemid 39244890)
18. Kussmaul WG, III, Buchbinder M, Whitlow PL, Aker UT, Heuser RR, King SB, Kent KM, Leon MB, Kolansky DM, Sandza JG, Jr. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol 1995;25:1685-92.
19. Slaughter PM, Chetty R, Flintoft VF, Lewis S, Sykora K, Beattie DM, Schwartz L. A single center randomized trial assessing use of a vascular hemostasis device vs. conventional manual compression following PTCA: what are the potential resource savings? Cathet Cardiovasc Diagn 1995;34:210-4.
20. Gwechenberger M, Katzenschlager R, Heinz G, Gottsauner-Wolf M, Probst P. Use of a collagen plug versus manual compression for sealing arterial puncture site after cardiac catheterization. Angiology 1997;48:121-6. (Pubitemid 27080197)
21. Ward SR, Casale P, Raymond R, Kussmaul WG, III, Simpfendorfer C. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Angio-Seal Investigators. Am J Cardiol 1998;81:569-72. (Pubitemid 28182419)
22. Gerckens U, Cattelaens N, Lampe EG, Grube E. Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol 1999;83:1658-63. (Pubitemid 29288011)
23. Noguchi T, Miyazaki S, Yasuda S, Baba T, Sumida H, Morii I, Daikoku S, Goto Y, Nonogi H. A randomised controlled trial of Prostar Plus for haemostasis in patients after coronary angioplasty. Eur J Vasc Endovasc Surg 2000;19:451-5. (Pubitemid 30333070)
24. Chevalier B, Lancelin B, Koning R, Henry M, Gommeaux A, Pilliere R, Elbaz M, Lefevre T, Boughalem K, Marco J, Dupouy P. Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial. Catheter Cardiovasc Interv 2003;58:285-91. (Pubitemid 36259212)
25. Duffin DC, Muhlestein JB, Allisson SB, Horne BD, Fowles RE, Sorensen SG, Revenaugh JR, Bair TL, Lappe DL. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol 2001;13:354-62. (Pubitemid 33759160)
26. Rickli H, Unterweger M, Sutsch G, Brunner-La Rocca HP, Sagmeister M, Ammann P, Amann FW. Comparison of costs and safety of a suture-mediated closure device with conventional man- ual compression after coronary artery interventions. Catheter Cardiovasc Interv 2002;57:297-302. (Pubitemid 35266261)
27. Assali AR, Sdringola S, Moustapha A, Ghani M, Salloum J, Schroth G, Fujise K, Anderson HV, Smalling RW, Rosales OR. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv 2003;58:1-5. (Pubitemid 36055291)
28. Schrader R, Steinbacher S, Burger W, Kadel C, Vallbracht C, Kaltenbach M. Collagen application for sealing of arterial puncture sites in comparison to pressure dressing: a randomized trial. J Invasive Cardiol 1999;11 Suppl B:14B-8B.
29. Silber S, Bjorvik A, Muhling H, Rosch A. Usefulness of colla- gen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times. Cathet Cardiovasc Diagn 1998;43:421-7. (Pubitemid 28153202)
30. Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA, Cutlip DE, Fitzpatrick M, Ho KK, Kuntz RE. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. Am J Cardiol 2000;85:864-9. (Pubitemid 30157854)
31. Carere RG, Webb JG, Buller CE, Wilson M, Rahman T, Spinelli J, Anis AH. Suture closure of femoral arterial puncture sites after coronary angioplasty followed by same-day discharge. Am Heart J 2000;139:52-8. (Pubitemid 30043624)
32. Wetter DR, Rickli H, von SA, Amann FW. Early sheath removal after coronary artery interventions with use of a suture-mediated closure device: clinical outcome and results of Doppler US evalua- tion. J Vasc Interv Radiol 2000;11:1033-7.
33. Tavris DR, Dey S, Albrecht-Gallauresi B, Brindis RG, Shaw R, Weintraub W, Mitchel K. Risk of local adverse events following cardiac catheterization by hemostasis device use - phase II. J Invasive Cardiol 2005;17:644-50.
34. Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. JACC Cardiovasc Interv 2008;1:317-26. (Pubitemid 351804185)